LBX Pharmacy Chain JSC
SSE:603883
LBX Pharmacy Chain JSC
Note Receivable
LBX Pharmacy Chain JSC
Note Receivable Peer Comparison
Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors
Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LBX Pharmacy Chain JSC
SSE:603883
|
Note Receivable
¥84.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LBX Pharmacy Chain JSC's Note Receivable?
Note Receivable
84.4m
CNY
Based on the financial report for Mar 31, 2024, LBX Pharmacy Chain JSC's Note Receivable amounts to 84.4m CNY.
What is LBX Pharmacy Chain JSC's Note Receivable growth rate?
Note Receivable CAGR 5Y
8%
Over the last year, the Note Receivable growth was 8%. The average annual Note Receivable growth rates for LBX Pharmacy Chain JSC have been 6% over the past three years , 8% over the past five years .